QVCGA vs. SKYE
QVCGA (QVC Group Inc) and SKYE (Skye Bioscience, Inc) are both stocks. QVCGA operates in Internet Retail (Consumer Cyclical), while SKYE operates in Biotechnology (Healthcare).
Performance
QVCGA vs. SKYE - Performance Comparison
Loading charts...
Returns By Period
QVCGA
- 1D
- 0.00%
- 1M
- —
- YTD
- —
- 6M
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
SKYE
- 1D
- 5.02%
- 1M
- -10.75%
- YTD
- 2.71%
- 6M
- -36.36%
- 1Y
- -68.31%
- 3Y*
- -41.13%
- 5Y*
- -54.71%
- 10Y*
- -40.24%
QVCGA vs. SKYE - Yearly Performance Comparison
| 2026 (YTD) | |
|---|---|
QVCGA QVC Group Inc | 0.00% |
SKYE Skye Bioscience, Inc | -9.40% |
Fundamentals
QVCGA:
$2.75M
SKYE:
$30.55M
QVCGA:
-$302.09
SKYE:
-$1.45
QVCGA:
$9.23B
SKYE:
$0.00
QVCGA:
$2.89B
SKYE:
-$180.01K
QVCGA:
$789.00M
SKYE:
$10.92M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
QVCGA vs. SKYE — Risk / Return Rank
QVCGA
SKYE
QVCGA vs. SKYE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for QVC Group Inc (QVCGA) and Skye Bioscience, Inc (SKYE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
Loading charts...
Sharpe Ratios by Period
| QVCGA | SKYE | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | — | -0.59 | — |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | -0.42 | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | -0.29 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | — | -0.36 | — |
Drawdowns
QVCGA vs. SKYE - Drawdown Comparison
The maximum QVCGA drawdown since its inception was 0.00%, smaller than the maximum SKYE drawdown of -99.96%. Use the drawdown chart below to compare losses from any high point for QVCGA and SKYE.
Loading charts...
Drawdown Indicators
| QVCGA | SKYE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | 0.00% | -99.96% | +99.96% |
Max Drawdown (1Y)Largest decline over 1 year | — | -87.85% | — |
Max Drawdown (3Y)Largest decline over 3 years | — | -96.79% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -98.66% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -99.83% | — |
Current DrawdownCurrent decline from peak | 0.00% | -99.94% | +99.94% |
Average DrawdownAverage peak-to-trough decline | 0.00% | -94.95% | +94.95% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 65.76% | — |
Volatility
QVCGA vs. SKYE - Volatility Comparison
Loading charts...
Volatility by Period
| QVCGA | SKYE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | — | 28.64% | — |
Volatility (6M)Calculated over the trailing 6-month period | — | 63.38% | — |
Volatility (1Y)Calculated over the trailing 1-year period | 0.00% | 115.33% | -115.33% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 0.00% | 130.81% | -130.81% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 0.00% | 137.31% | -137.31% |
Dividends
QVCGA vs. SKYE - Dividend Comparison
Neither QVCGA nor SKYE has paid dividends to shareholders.
Financials
QVCGA vs. SKYE - Financials Comparison
This section allows you to compare key financial metrics between QVC Group Inc and Skye Bioscience, Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Find the right allocation for QVCGA and SKYE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer